Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With WiFiMed
Date:2/12/2008

NEW YORK, Feb. 12 /PRNewswire/ -- On February 11, Greg Vacca, CEO of WiFiMed Holdings Company, Inc. (OTC Bulletin Board: WIFM) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones for which investors should watch.

To hear the interview, visit http://www.wallst.net and click "Interviews." Locate the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or enter the company's ticker symbol in the Search Archive window.

Ask Greg Vacca a question, post a comment on his personal page, and join his financial social network today at http://www.mywallst.net.

About WiFiMed Holdings:

WiFiMed Holdings Company, Inc., through its wholly owned subsidiaries WiFiMed, Inc. and EncounterPRO Healthcare Resources, Inc., offers proprietary solutions enabling physicians and other healthcare providers to document the physician-patient encounter through continuously updated state-of-the-art technologies. WiFiMed Inc.'s proprietary product, Tablet MD(R) and EncounterPRO Healthcare Resources, Inc.'s proprietary product, EncounterPRO(R) EHR, were developed to assist physicians and health care providers manage patient workflow. Tablet MD(R) operates on a tablet PC and manages patient medical information, consultation notes, prescriptions, records, and charts through five proprietary technologies. The EncounterPRO(R) EHR gives physicians and staff the most flexible and sophisticated workflow engine available in an EHR. This premier software requires virtually no level of computer literacy and works off touch screens, Tablet PCs or a mouse as the primary means of data input. Both products have been designed to meet the Health Insurance Portability and Accountability Act (HIPAA) requirements and are designed to reduce medical errors, documentation time, overhead, and time spent filing insurance claims.

About WallSt.net

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The website is a leading provider of business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. owns http://www.mywallst.net, a financial social network for investors and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. WallStreet Direct also owns and operates WallStRadio, a business and finance podcast website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from WiFiMed Holdings Company, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
2. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
3. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
5. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
6. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
7. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
8. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
9. Merrell Updates Performance Line with the Launch of OrthoLite Insoles
10. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
11. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC is pleased ... professionals throughout the country. The Guard was specifically designed to handle each element ... training, regulatory updates, and compliance coaching. , In addition to meeting the compliance ...
(Date:2/10/2016)... SAN FRANCISCO, Calif. (PRWEB) , ... February 10, 2016 , ... ... category: Best Water Brand. There were three leading bottled water brand owners that topped ... edge services that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, ...
(Date:2/10/2016)... ... 2016 , ... Ongoing news of the ravages of traumatic brain injury (TBI) ... survey that takes a closer look at cases of TBI being managed by their ... TBI among the aging population, and identifies the challenges associated with their care. , ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Gout is ... and brings pain that is often severe, with intense swelling and redness. It is ... eight million people, but older adults are the most susceptible, according to the February ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 Urologix, the market leader for in-office ... Prostatic Hyperplasia (BPH), announces new private ownership and is ... medical device industry veteran of more than 20 years, ... Plymouth, Minn. The ... and Prostiva® RF Therapy, will continue to be broadly ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: